Question

A 63-year-old man with long-standing type 2 diabetes, prior MI and eGFR 70 mL/min/1.73 m² has HbA1c 7.5% on maximised metformin. According to the Australian type 2 diabetes glycaemic management algorithm, which additional agent is preferred for cardiovascular benefit?

Accepted Answer

SGLT2 inhibitor or GLP-1 receptor agonist

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

DPP-4 inhibitor

Answer

Basal insulin

Practice question

A 63-year-old man with long-standing type 2 diabetes, prior MI and eGFR 70 mL/min/1.73 m² has HbA1c 7.5% on maximised metformin. According to the Australian type 2 diabetes glycaemic management algorithm, which additional agent is preferred for cardiovascular benefit?